Clinical Trial Update: Bone Mineral Density Effects of Zoledronate in Postmenopausal Women With Breast Cancer [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating the effects of zoledronate on bone mineral density in postmenopausal women with breast cancer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• Zoledronate (zoledronic acid)

Snippet

Sponsor: University of Wisconsin, Madison | Conditions: Breast Cancer | Phase 2 | Status: COMPLETED | Results posted: 2018-01-05